Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership
Merus Buyout Frenzy: Genmab Rumored to Lead the Race, Sending Retail Traders Into a Tizzy
Biotech Blockbuster Alert: Genmab Edges Closer to Game-Changing Merus Acquisition